New patent for Azurity drug XATMEP

   December 7, 2021    Comments Off on New patent for Azurity drug XATMEP    Posted in: Patent Added

Annual Drug Patent Expirations for XATMEP Xatmep is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are four patents protecting…

The post New patent for Azurity drug XATMEP appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog